(PharmaNewsWire.Com, February 26, 2018 ) The global apheresis market is estimated to reach USD 2.06 Billion by 2021, at a CAGR of 7.7% during the forecast period. The increasing demand for blood components and growing concerns regarding blood safety across the globe, rising prevalence of various blood disorders, increasing number of surgical procedures and emergency care cases in hospitals around the world are driving market growth. Extending reach of apheresis in the untapped pediatric segment and growth in emerging markets due to increasing investments presents significant growth opportunities for players in this market. However, high costs of apheresis machines & procedures and scarcity of qualified donors are the major restraining factors for this market.
In this report, the market is segmented on the basis of procedure, product type, technology, application, and region. The research report discusses key market drivers, restraints, opportunities, and challenges in the global apheresis market and its submarkets. Based on product type, the market is segmented into devices and disposables. The disposables segment accounted for the largest share of the market in 2015; it is expected to grow at the highest CAGR during the forecast period. The increasing demand for disposables due to the rising number of therapeutic apheresis procedures being performed globally and the increasing trend towards apheresis blood collections are expected to drive the growth of this segment.
Based on technology, apheresis market is segmented into centrifugation and membrane separation technologies. The centrifugation technology segment accounted for the largest share of the global apheresis market in 2015. The large share of this segment can be attributed to the wide applications of centrifugation technology in the separation of plasma and cellular components of the blood.
In this report, the global apheresis market has been studied at the regional and country levels. In 2015, North America represented the largest regional market, followed by Europe. While North America will continue to dominate the market during the forecast period, the Asia-Pacific region is expected to register the highest growth. The growth of this regional segment is driven by the improving healthcare infrastructure, significant economic development in emerging markets, and rising focus of key market players in this region.
The major players in the global apheresis market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan).
About Us: Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
